pbabe vector Search Results


90
Cell Biolabs Inc empty pbabe vector
Empty Pbabe Vector, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/empty pbabe vector/product/Cell Biolabs Inc
Average 90 stars, based on 1 article reviews
empty pbabe vector - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cell Biolabs Inc pbabe-puromycin vectors encoding gfp
Pbabe Puromycin Vectors Encoding Gfp, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pbabe-puromycin vectors encoding gfp/product/Cell Biolabs Inc
Average 90 stars, based on 1 article reviews
pbabe-puromycin vectors encoding gfp - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cell Biolabs Inc pbabe retroviral vector
Pbabe Retroviral Vector, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pbabe retroviral vector/product/Cell Biolabs Inc
Average 90 stars, based on 1 article reviews
pbabe retroviral vector - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Amaxa pbabe-puromycin vectors
Pbabe Puromycin Vectors, supplied by Amaxa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pbabe-puromycin vectors/product/Amaxa
Average 90 stars, based on 1 article reviews
pbabe-puromycin vectors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cell Biolabs Inc pbabed-puromycin vectors encoding the desired construct (6 mg)
Pbabed Puromycin Vectors Encoding The Desired Construct (6 Mg), supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pbabed-puromycin vectors encoding the desired construct (6 mg)/product/Cell Biolabs Inc
Average 90 stars, based on 1 article reviews
pbabed-puromycin vectors encoding the desired construct (6 mg) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cell Biolabs Inc pbabed-puro vectors
Pbabed Puro Vectors, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pbabed-puro vectors/product/Cell Biolabs Inc
Average 90 stars, based on 1 article reviews
pbabed-puro vectors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
BioInnovatise Inc pbabe-puro based vectors
Pbabe Puro Based Vectors, supplied by BioInnovatise Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pbabe-puro based vectors/product/BioInnovatise Inc
Average 90 stars, based on 1 article reviews
pbabe-puro based vectors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GenScript corporation isoforms of ptbp1 and hnrnpl carrying a c-terminal hemagglutinin (ha) epitope tag
CFTR mRNA abundance in 16HBEs after knockdown (KD) of PTBP1 or <t>HNRNPL.</t> (A) qPCR data quantifying PTBP1 mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (B) qPCR data quantifying HNRNPL mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or an HNRNPL KD siRNA (+). (C) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (D) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a HNRNPL KD siRNA (+). For panels A–D, each column represents the mean ± SD of changes in expression; each symbol represents an individual data point normalized to KRT18 or PPIA from at least three independent experiments (n = 36–54). Data in panels A & B are expressed relative to the scrambled control for each cell line = 100 %. Data in panels C & D are expressed relative to the scrambled control for the WT cell line = 100 %. Statistical analysis was performed for panels A & B using the Welch's unpaired t -test. In panels C & D, statistical analysis was performed using one-way ANOVA. **** indicates p < 0.0001 when comparing the control with an experimental cohort.
Isoforms Of Ptbp1 And Hnrnpl Carrying A C Terminal Hemagglutinin (Ha) Epitope Tag, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/isoforms of ptbp1 and hnrnpl carrying a c-terminal hemagglutinin (ha) epitope tag/product/GenScript corporation
Average 90 stars, based on 1 article reviews
isoforms of ptbp1 and hnrnpl carrying a c-terminal hemagglutinin (ha) epitope tag - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
DWK Life Sciences retroviral vectors pbabe
CFTR mRNA abundance in 16HBEs after knockdown (KD) of PTBP1 or <t>HNRNPL.</t> (A) qPCR data quantifying PTBP1 mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (B) qPCR data quantifying HNRNPL mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or an HNRNPL KD siRNA (+). (C) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (D) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a HNRNPL KD siRNA (+). For panels A–D, each column represents the mean ± SD of changes in expression; each symbol represents an individual data point normalized to KRT18 or PPIA from at least three independent experiments (n = 36–54). Data in panels A & B are expressed relative to the scrambled control for each cell line = 100 %. Data in panels C & D are expressed relative to the scrambled control for the WT cell line = 100 %. Statistical analysis was performed for panels A & B using the Welch's unpaired t -test. In panels C & D, statistical analysis was performed using one-way ANOVA. **** indicates p < 0.0001 when comparing the control with an experimental cohort.
Retroviral Vectors Pbabe, supplied by DWK Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/retroviral vectors pbabe/product/DWK Life Sciences
Average 90 stars, based on 1 article reviews
retroviral vectors pbabe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Novartis ha-mtor cdna containing pbabe-puro retroviral vectors
CFTR mRNA abundance in 16HBEs after knockdown (KD) of PTBP1 or <t>HNRNPL.</t> (A) qPCR data quantifying PTBP1 mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (B) qPCR data quantifying HNRNPL mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or an HNRNPL KD siRNA (+). (C) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (D) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a HNRNPL KD siRNA (+). For panels A–D, each column represents the mean ± SD of changes in expression; each symbol represents an individual data point normalized to KRT18 or PPIA from at least three independent experiments (n = 36–54). Data in panels A & B are expressed relative to the scrambled control for each cell line = 100 %. Data in panels C & D are expressed relative to the scrambled control for the WT cell line = 100 %. Statistical analysis was performed for panels A & B using the Welch's unpaired t -test. In panels C & D, statistical analysis was performed using one-way ANOVA. **** indicates p < 0.0001 when comparing the control with an experimental cohort.
Ha Mtor Cdna Containing Pbabe Puro Retroviral Vectors, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ha-mtor cdna containing pbabe-puro retroviral vectors/product/Novartis
Average 90 stars, based on 1 article reviews
ha-mtor cdna containing pbabe-puro retroviral vectors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Armata Pharmaceuticals recombinant viruses generated using bosc cells and the vectors pbabe-puro and pbabe- haras61l -puro
CFTR mRNA abundance in 16HBEs after knockdown (KD) of PTBP1 or <t>HNRNPL.</t> (A) qPCR data quantifying PTBP1 mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (B) qPCR data quantifying HNRNPL mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or an HNRNPL KD siRNA (+). (C) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (D) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a HNRNPL KD siRNA (+). For panels A–D, each column represents the mean ± SD of changes in expression; each symbol represents an individual data point normalized to KRT18 or PPIA from at least three independent experiments (n = 36–54). Data in panels A & B are expressed relative to the scrambled control for each cell line = 100 %. Data in panels C & D are expressed relative to the scrambled control for the WT cell line = 100 %. Statistical analysis was performed for panels A & B using the Welch's unpaired t -test. In panels C & D, statistical analysis was performed using one-way ANOVA. **** indicates p < 0.0001 when comparing the control with an experimental cohort.
Recombinant Viruses Generated Using Bosc Cells And The Vectors Pbabe Puro And Pbabe Haras61l Puro, supplied by Armata Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant viruses generated using bosc cells and the vectors pbabe-puro and pbabe- haras61l -puro/product/Armata Pharmaceuticals
Average 90 stars, based on 1 article reviews
recombinant viruses generated using bosc cells and the vectors pbabe-puro and pbabe- haras61l -puro - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Promega pbabe-puro retroviral vector
CFTR mRNA abundance in 16HBEs after knockdown (KD) of PTBP1 or <t>HNRNPL.</t> (A) qPCR data quantifying PTBP1 mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (B) qPCR data quantifying HNRNPL mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or an HNRNPL KD siRNA (+). (C) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (D) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a HNRNPL KD siRNA (+). For panels A–D, each column represents the mean ± SD of changes in expression; each symbol represents an individual data point normalized to KRT18 or PPIA from at least three independent experiments (n = 36–54). Data in panels A & B are expressed relative to the scrambled control for each cell line = 100 %. Data in panels C & D are expressed relative to the scrambled control for the WT cell line = 100 %. Statistical analysis was performed for panels A & B using the Welch's unpaired t -test. In panels C & D, statistical analysis was performed using one-way ANOVA. **** indicates p < 0.0001 when comparing the control with an experimental cohort.
Pbabe Puro Retroviral Vector, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pbabe-puro retroviral vector/product/Promega
Average 90 stars, based on 1 article reviews
pbabe-puro retroviral vector - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


CFTR mRNA abundance in 16HBEs after knockdown (KD) of PTBP1 or HNRNPL. (A) qPCR data quantifying PTBP1 mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (B) qPCR data quantifying HNRNPL mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or an HNRNPL KD siRNA (+). (C) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (D) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a HNRNPL KD siRNA (+). For panels A–D, each column represents the mean ± SD of changes in expression; each symbol represents an individual data point normalized to KRT18 or PPIA from at least three independent experiments (n = 36–54). Data in panels A & B are expressed relative to the scrambled control for each cell line = 100 %. Data in panels C & D are expressed relative to the scrambled control for the WT cell line = 100 %. Statistical analysis was performed for panels A & B using the Welch's unpaired t -test. In panels C & D, statistical analysis was performed using one-way ANOVA. **** indicates p < 0.0001 when comparing the control with an experimental cohort.

Journal: Heliyon

Article Title: RNA binding proteins PTBP1 and HNRNPL regulate CFTR mRNA decay

doi: 10.1016/j.heliyon.2023.e22281

Figure Lengend Snippet: CFTR mRNA abundance in 16HBEs after knockdown (KD) of PTBP1 or HNRNPL. (A) qPCR data quantifying PTBP1 mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (B) qPCR data quantifying HNRNPL mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or an HNRNPL KD siRNA (+). (C) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a PTBP1 KD siRNA (+). (D) qPCR data quantifying CFTR mRNA abundance in WT, G542X, or W1282X 16HBEs after transfection with a scrambled control siRNA (−) or a HNRNPL KD siRNA (+). For panels A–D, each column represents the mean ± SD of changes in expression; each symbol represents an individual data point normalized to KRT18 or PPIA from at least three independent experiments (n = 36–54). Data in panels A & B are expressed relative to the scrambled control for each cell line = 100 %. Data in panels C & D are expressed relative to the scrambled control for the WT cell line = 100 %. Statistical analysis was performed for panels A & B using the Welch's unpaired t -test. In panels C & D, statistical analysis was performed using one-way ANOVA. **** indicates p < 0.0001 when comparing the control with an experimental cohort.

Article Snippet: Generation of 16HBEs stably expressing the PTBP1 or HNRNPL isoforms: Isoforms of PTBP1 and HNRNPL carrying a C-terminal hemagglutinin (HA) epitope tag from the pcDNA3.1(+) vector were purchased from GenScript Biotech Corporation.

Techniques: Knockdown, Transfection, Control, Expressing

CFTR mRNA decay rates in 16HBEs after knockdown (KD) of PTBP1 or HNRNPL. 16HBEs expressing WT or G542X CFTR were transfected with 90 pmol of a scrambled, control siRNA or siRNAs to knockdown PTBP1 or HNRNPL. 48 h after siRNA transfection, 10 μg/mL of actinomycin D was added to the media and RNA was harvested at the indicated times and subjected to RT-qPCR using equal cDNA amounts to quantify the amount of: (A) CFTR or (B) KRT18 remaining after actinomycin D addition relative to the control at time = 0. The data shown are the mean ± SD of the percent of mRNA remaining at each time point, where each experiment was performed twice in quadruplicate (n = 8). (C) Linear regression was performed using semi-log graphs to determine the rate (slope) and half-life of each decay curve, which were tested to determine whether they differed among the cohorts. In the legend, the p values in black font indicate values compared to the WT control; the p values in orange font indicate values compared to the G542X control. p values < 0.05 indicate significant differences between slopes. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Journal: Heliyon

Article Title: RNA binding proteins PTBP1 and HNRNPL regulate CFTR mRNA decay

doi: 10.1016/j.heliyon.2023.e22281

Figure Lengend Snippet: CFTR mRNA decay rates in 16HBEs after knockdown (KD) of PTBP1 or HNRNPL. 16HBEs expressing WT or G542X CFTR were transfected with 90 pmol of a scrambled, control siRNA or siRNAs to knockdown PTBP1 or HNRNPL. 48 h after siRNA transfection, 10 μg/mL of actinomycin D was added to the media and RNA was harvested at the indicated times and subjected to RT-qPCR using equal cDNA amounts to quantify the amount of: (A) CFTR or (B) KRT18 remaining after actinomycin D addition relative to the control at time = 0. The data shown are the mean ± SD of the percent of mRNA remaining at each time point, where each experiment was performed twice in quadruplicate (n = 8). (C) Linear regression was performed using semi-log graphs to determine the rate (slope) and half-life of each decay curve, which were tested to determine whether they differed among the cohorts. In the legend, the p values in black font indicate values compared to the WT control; the p values in orange font indicate values compared to the G542X control. p values < 0.05 indicate significant differences between slopes. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: Generation of 16HBEs stably expressing the PTBP1 or HNRNPL isoforms: Isoforms of PTBP1 and HNRNPL carrying a C-terminal hemagglutinin (HA) epitope tag from the pcDNA3.1(+) vector were purchased from GenScript Biotech Corporation.

Techniques: Knockdown, Expressing, Transfection, Control, Quantitative RT-PCR

CFTR mRNA abundance in 16HBEs exogenously expressing PTBP1 and HNRNPL isoforms. (A) Western blots of PTBP1 and HNRNPL isoforms in WT, G542X, or W1282X 16HBEs using an antibody to the C-terminal HA epitope tag. Full, non-adjusted blots are shown in . (B) qPCR data quantifying CFTR mRNA abundance in WT, G542X, and W1282X 16HBEs stably expressing PTBP1 and HNRNPL variants. The data is expressed relative to the scrambled control for each cell line = 1. Each column represents the mean ± SD of changes in expression; each symbol represents an individual data point normalized to KRT18 or PPIA from at two independent experiments performed in quadruplicate (n = 16). Statistical analysis was performed using the Welch's unpaired t -test; **** indicates p < 0.0001 when comparing the control with the experimental cohort for each cell line.

Journal: Heliyon

Article Title: RNA binding proteins PTBP1 and HNRNPL regulate CFTR mRNA decay

doi: 10.1016/j.heliyon.2023.e22281

Figure Lengend Snippet: CFTR mRNA abundance in 16HBEs exogenously expressing PTBP1 and HNRNPL isoforms. (A) Western blots of PTBP1 and HNRNPL isoforms in WT, G542X, or W1282X 16HBEs using an antibody to the C-terminal HA epitope tag. Full, non-adjusted blots are shown in . (B) qPCR data quantifying CFTR mRNA abundance in WT, G542X, and W1282X 16HBEs stably expressing PTBP1 and HNRNPL variants. The data is expressed relative to the scrambled control for each cell line = 1. Each column represents the mean ± SD of changes in expression; each symbol represents an individual data point normalized to KRT18 or PPIA from at two independent experiments performed in quadruplicate (n = 16). Statistical analysis was performed using the Welch's unpaired t -test; **** indicates p < 0.0001 when comparing the control with the experimental cohort for each cell line.

Article Snippet: Generation of 16HBEs stably expressing the PTBP1 or HNRNPL isoforms: Isoforms of PTBP1 and HNRNPL carrying a C-terminal hemagglutinin (HA) epitope tag from the pcDNA3.1(+) vector were purchased from GenScript Biotech Corporation.

Techniques: Expressing, Western Blot, Stable Transfection, Control

Model of how PTBP1 and HNRNPL may regulate NMD of CFTR mRNAs. (A) PTBP1, but not HNRNPL, regulates WT CFTR mRNA abundance, likely by protecting these transcripts from EJC-independent NMD that is mediated by the accumulation of UPF1 on the long 3′ UTR. (B) Both PTBP1 and HNRNPL regulate PTC-containing CFTR mRNA abundance, suggesting that PTC-containing CFTR transcripts may be subject to both EJC- and long 3′ UTR-mediated NMD. We speculate that PTBP1 may protect CFTR mRNAs from 3′ UTR mediated NMD, while HNRNPL may protect CFTR mRNAs from EJC-mediated NMD that likely recruits different NMD-associated factors based on the location of the PTC. CU and CA represent binding motifs for PTBP1 and HNRNPL, respectively.

Journal: Heliyon

Article Title: RNA binding proteins PTBP1 and HNRNPL regulate CFTR mRNA decay

doi: 10.1016/j.heliyon.2023.e22281

Figure Lengend Snippet: Model of how PTBP1 and HNRNPL may regulate NMD of CFTR mRNAs. (A) PTBP1, but not HNRNPL, regulates WT CFTR mRNA abundance, likely by protecting these transcripts from EJC-independent NMD that is mediated by the accumulation of UPF1 on the long 3′ UTR. (B) Both PTBP1 and HNRNPL regulate PTC-containing CFTR mRNA abundance, suggesting that PTC-containing CFTR transcripts may be subject to both EJC- and long 3′ UTR-mediated NMD. We speculate that PTBP1 may protect CFTR mRNAs from 3′ UTR mediated NMD, while HNRNPL may protect CFTR mRNAs from EJC-mediated NMD that likely recruits different NMD-associated factors based on the location of the PTC. CU and CA represent binding motifs for PTBP1 and HNRNPL, respectively.

Article Snippet: Generation of 16HBEs stably expressing the PTBP1 or HNRNPL isoforms: Isoforms of PTBP1 and HNRNPL carrying a C-terminal hemagglutinin (HA) epitope tag from the pcDNA3.1(+) vector were purchased from GenScript Biotech Corporation.

Techniques: Binding Assay